Berlin - Delayed Quote EUR

Bayer AG (BAYA.BE)

6.80

0.00

(0.00%)

As of 12:20 PM GMT+2. Market Open.

One CEO’s Radical Fix for Corporate Troubles: Purge the Bosses

Bayer Chief Executive Bill Anderson is throwing out the corporate playbook for a management plan that shifts more decisions to workers.

The Wall Street Journal last month

BAYRY

BAYZF
New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding

Several blood thinners are being developed that could prevent the clots that cause heart attacks and strokes—without some of the side effects.

The Wall Street Journal last month

BMY

CELG-RT

MRK
Bayer CEO: Now is not the time to break the company up

Life sciences company Bayer (BAYRY, BAYN.DE) isn't breaking itself up right now. Bayer CEO Bill Anderson says, "This is not a good time to be... breaking up the firm," given the company's need to rebuild its pharmaceutical pipeline and battle the ongoing litigation stemming from the weedkiller Roundup. When it comes to the Roundup lawsuits, Bayer has "adequately provisioned" for the costs of those suits, Anderson says. Overall, "the fundamental fact is, that glyphosate, Roundup, is safe," Anderson states, adding that Bayer is "a scientifically-driven company and we have this litigation thing that's not scientific." On the pharmaceutical business, Anderson says the group is "in a bit of a transition phase." "We got a couple of major medicines that are losing patent protection over the next few years. So we are busy rebuilding the pipeline right now," he tells Yahoo Finance. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Stephanie Mikulich.

Yahoo Finance Video last month

BAYRY

BAYZF
Inflation: Over-the-counter drug prices leap year over year

Alongside other sectors of the consumer economy, nonprescription drug prices saw prices rise 9.3% year-over-year. The insurance industry, health insurance and auto insurance providers in particular, have been beset by inflationary challenges. Yahoo Finance Health Reporter Anjalee Khemlani details the price trends for over-the-counter drugs, referencing a statement from Bayer (BAYRY) from its third-quarter 2023 in relation to how pharmaceutical companies are trying to offset inflation. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.

Yahoo Finance Video last month

BAYRY

BAYZF
Heard on the Street: Does Bayer Have the Formula to Avoid a Breakup?

Bayer thinks it can get back to health with little more than a new diet and fitness regime. Investors had called for major surgery at the German company after years of problems stemming in part from its [$63 billion acquisition of U.S. agrochemical company Monsanto](https://www.wsj.com/articles/monsanto-gives-investors-a-new-reason-to-avoid-bayer-1534179293).

The Wall Street Journal last month

BAYRY

BAYZF

HLN
Bayer Decides Against Splitting Into Separate Units for Now

The German pharmaceutical and agricultural conglomerate has been looking into various options for the group but Chief Executive Bill Anderson said Bayer doesn’t currently plan to pursue a split into separate units.

The Wall Street Journal last month

BAYRY

BAYZF
Health Care Roundup: Market Talk

Find insights on Grifols, Bayer, Fresenius Medical Care, and more in the latest Market Talks covering the Health Care sector.

The Wall Street Journal 2 months ago

BAYRY

BAYZF
Aspirin, a Pioneering Wonder Drug

For ages the most reliable medical advice was also the most simple: Take two aspirin and call me in the morning. Willow bark, a distant ancestor of aspirin, was a popular ingredient in ancient remedies to relieve pain and treat skin problems. Edward Stone, an English clergyman, noticed its extremely bitter taste was similar to that of the cinchona tree, the source of the costly malaria drug quinine.

The Wall Street Journal 2 months ago

BAYRY

BAYZF
Stocks to Watch Monday: SoFi, iRobot, Franklin Resources, Chipotle

[**SoFi Technologies (SOFI)**](https://www.wsj.com/market-data/quotes/SOFI): The digital financial-services provider [swung to a quarterly profit](https://www.wsj.com/livecoverage/stock-market-today-dow-jones-01-29-2024/card/sofi-stock-jumps-after-company-swings-to-a-profit-xBujQASseYaXEyi6xnkw), as revenue jumped by more than a third.

The Wall Street Journal 2 months ago

PHG

RYLPF

CMG
Bayer Shares Fall After Jury Orders $2.25 Billion in Damages in Roundup Case

Bayer shares slumped after the German pharmaceutical and agricultural company was ordered to pay $2.25 billion in damages in the latest setback in its legal battle over its Roundup weed killer.

The Wall Street Journal 2 months ago

BAYRY

BAYZF
MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa

Bayer's commercial license covers soil applications of MustGrow's mustard-based biocontrol technologies in Europe, Middle East and Africa. MustGrow to receive upfront license fees and milestone payments, royalties, and manufacturing sales linked to development and commercial achievements. Saskatoon, Saskatchewan--(Newsfile Corp. - December 11, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") is pleased to announce the signing of a collaboration agreement (the

Newsfile 4 months ago

MGROF

BAYRY

BAYZF
Bayer stock plunges after drug trial halted

Bayer (BAYRY) shares closed 17% lower on Monday after the company halted a trial for a blood-thinning drug due to "lack of efficacy." The news sent shares of Bristol Myers Squibb (BMY) lower because it's developing a similar drug. Also impacting Bayer shares is the news that the company was ordered to pay $1.56 billion in a lawsuit involving its Roundup weedkiller. Yahoo Finance Live breaks down the stock action. Click here to watch the full interview on the Yahoo Finance YouTube page or you can watch this full episode of Yahoo Finance Live here.

Yahoo Finance Video 5 months ago

BAYRY

BAYZF

BMY
From Parkinson's to food science: Bayer US President talks tech advancements in health care

Most Americans know Bayer (BAYN.DE) for its over-the-counter medicines like Aleve and Claritin. But that's not all the company does. Bayer U.S. President Sebastian Guth tells Yahoo Finance's Anjalee Khemlani that the company just opened a new facility to focus on cell and gene therapies to help treat diseases such as Parkinson's. Guth also weighed in on the company's acquisition of agricultural biotechnology company Monsanto. Guth says the company is "squarely focused on innovation in a space that continues to require innovation. Feeding the world is a very, very significant task and food is a medicine." For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

Yahoo Finance Video 6 months ago

BAYRY

BAYZF
Medicare price negotiation list: What it means for pharma companies

On Tuesday, the Biden administration listed ten drugs subject to Medicare price negotiations. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the list and how this may impact the pharmaceutical companies who profit from these drugs.   The ten drugs and pharma companies impacted are:  Eliquis - Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance - Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia - Merck (MRK) Farxiga - AstraZeneca (AZN) Entresto - Novartis (NVS) Enbrel - Amgen (AMGN) Imbruvica - Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara - Johnson & Johnson (JNJ) Fiasp, NovoLog - Novo Nordisk (NVO)

Yahoo Finance Video 7 months ago

MRK

PFE

BMY
Designing the Keys To Unlock the Future of Sustainable Protection

Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative.

ACCESSWIRE 7 months ago

BAYRY

BAYZF
Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS

UBS believes there is little chance the lawsuits brought on by pharma companies will delay Medicare pricing negotiations.

Yahoo Finance 7 months ago

JNJ

LLY

BAYRY
Bayer is Using Unprecedented Insights in Unexpected Ways on the Farm

NORTHAMPTON, MA / ACCESSWIRE / August 10, 2023 / What's the value of data? Well, like any other tool, it depends on how you use it. In agriculture, data is proving to be an essential foundation for building more efficient, productive and profitable ...

ACCESSWIRE 8 months ago

BAYRY

BAYZF
Bayer Collaborates in Value-Chain Partnerships

NORTHAMPTON, MA / ACCESSWIRE / August 2, 2023 / BayerAs no one can overcome every challenge alone, we establish crop value-chain partnerships to provide smallholder farmers with high-quality inputs, agronomic knowledge, cost-effective financing and ...

ACCESSWIRE 8 months ago

BAYRY

BAYZF
DKsilos Is the Crop of the Cream

Bayer isn't in the cattle business. At least, we weren't. That was before we started asking big questions about small farms.

ACCESSWIRE 8 months ago

BAYRY

BAYZF
Bayer Supports Smallholder-Centric Solutions

NORTHAMPTON, MA / ACCESSWIRE / July 18, 2023 / Bayer: Our increased focus on smallholder farmers means an increase in products tailored to their needs. The pressure to succeed falls directly on the shoulders of smallholder farmers. If a disease ...

ACCESSWIRE 9 months ago

BAYRY

BAYZF

Performance Overview

Return	BAYA.BE	DAX PERFORMANCE-INDEX
YTD	-19.05%	+7.29%
1-Year	-52.55%	+13.30%
3-Year	-43.36%	+17.63%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bayer AG (BAYA.BE)

One CEO’s Radical Fix for Corporate Troubles: Purge the Bosses

New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding

Bayer CEO: Now is not the time to break the company up

Inflation: Over-the-counter drug prices leap year over year

Heard on the Street: Does Bayer Have the Formula to Avoid a Breakup?

Bayer Decides Against Splitting Into Separate Units for Now

Health Care Roundup: Market Talk

Aspirin, a Pioneering Wonder Drug

Stocks to Watch Monday: SoFi, iRobot, Franklin Resources, Chipotle

Bayer Shares Fall After Jury Orders $2.25 Billion in Damages in Roundup Case

MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa

Bayer stock plunges after drug trial halted

From Parkinson's to food science: Bayer US President talks tech advancements in health care

Medicare price negotiation list: What it means for pharma companies

Designing the Keys To Unlock the Future of Sustainable Protection

Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS

Bayer is Using Unprecedented Insights in Unexpected Ways on the Farm

Bayer Collaborates in Value-Chain Partnerships

DKsilos Is the Crop of the Cream

Bayer Supports Smallholder-Centric Solutions

Performance Overview